CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
about
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeDamage control: cellular mechanisms of plasma membrane repairActivation of myeloid cell-specific adhesion class G protein-coupled receptor EMR2 via ligation-induced translocation and interaction of receptor subunits in lipid raft microdomainsEvolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathologyCD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cellsMorphology and expression status investigations of specific surface markers on B-cell chronic lymphocytic leukemia cells.Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.CD38 and chronic lymphocytic leukemia: a decade later.Identification of human plasma cells with a lamprey monoclonal antibody.Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes.Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.CD38 through the life of a murine B lymphocyte.CD19: a biomarker for B cell development, lymphoma diagnosis and therapy.Targeting the "cytokine storm" for therapeutic benefit.Ectoenzymes in leukocyte migration and their therapeutic potential.The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.Emerging drugs and combinations to treat multiple myeloma.Inflammation, the microenvironment and chronic lymphocytic leukemia.Mechanism-based small molecule probes for labeling CD38 on live cells.Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab.The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.Daratumumab: Dawn of a New Paradigm in Multiple Myeloma?The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytesCD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of ResistanceCells with stemness features are generated from in vitro transformed human fibroblasts
P2860
Q27015933-B11AAD62-3E04-4A87-92C8-85508CC5C89AQ27022016-930AA8F7-4F47-4FEB-B99C-32C2BA4A847EQ28259067-E4348BB7-B070-4462-A0F6-C17C26FDEB74Q28287124-AAE258C8-686E-463A-BFAA-279A645FF4F5Q30484805-A2196BAE-B56B-47BE-806A-0A2949D55538Q31126777-913C76D8-6127-481F-9233-6220757F8AD4Q34005556-9E7F3DEC-DB43-418C-A2C4-ED45FFFE443EQ36236545-C4325657-FA86-4109-A5BD-1464EAAD25EEQ36384860-222000F6-2681-44A6-903C-08015838DC9FQ36615126-549E5459-BAA0-474F-8729-805E37FCCC7CQ36862077-B4C85351-E3CC-42DD-BDB0-9EE05388E375Q36995176-D9EAC433-9D5B-4320-BC90-AB6F044A5665Q37588785-A4C3A262-2125-451B-B2AB-3CA0FAF982E7Q37640501-06D344E8-742B-4C28-BB0B-409165BE3900Q37704928-846BB666-4EC3-4DC5-8506-1D60B4903524Q37771664-5C1A4C82-64F0-4820-8D8A-97331543DB85Q37868181-96BCE396-7AF3-47DC-B04A-7BC09850B552Q37929089-9BE961CE-28D9-4BB3-8D1F-80EAAA537E52Q38064963-A37D9083-90A3-4F60-9BBE-CBC40B1B0C8FQ38071254-DFCFB22A-1062-4C19-AAFC-3B63597071E1Q38196724-C7BD7999-1F1B-4F99-BE2F-A0D490580379Q39404177-1E7608AF-4453-4F58-8123-7E34002E5A29Q40575818-A23070E5-CD2C-44D2-945A-DE34228F4DDAQ41694198-00E95F3A-204F-4EA9-91B7-1DFE25FE6E20Q42638924-775CD350-A499-4DEE-82E5-1C8672DF3534Q43178662-C701AEEA-6571-40D2-93BE-317043C15337Q45879904-7F447D9A-DF0C-447E-8401-0A1E62A0F35FQ47660573-3806E360-E99A-4C83-B387-8094C32555DEQ53271932-7A9B4ABC-11EE-4935-B08F-D1B2AEFEE1DFQ55021985-442CF317-39F6-4829-9A5B-F57F047C0A9EQ57058779-7BF0684D-7C91-446D-BDE3-7AB70B5F222BQ57191729-EFADAAC8-3185-4DB7-A85B-58D11FBE92D8Q58740672-84EC16D6-D552-4C82-998C-AE9A00D9B65F
P2860
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
@en
type
label
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
@en
prefLabel
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
@en
P2093
P1433
P1476
CD38/CD19: a lipid raft-dependent signaling complex in human B cells.
@en
P2093
Fabio Malavasi
Luciana Bergui
Paola Omede'
Richard Billington
Silvia Deaglio
Tiziana Vaisitti
P304
P356
10.1182/BLOOD-2006-12-061812
P407
P577
2007-02-27T00:00:00Z